tiprankstipranks
Trending News
More News >
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Compare Travere Therapeutics (TVTX) vs. Competitors

Compare
575 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Travere Therapeutics
$27.87
$2.49B
-25.70
50.89%
11 Buy
2 Hold
0 Sell
Strong Buy
Galapagos
$33.52
$2.22B
-4.50
40.25%
1 Buy
1 Hold
2 Sell
Hold
Arcutis Biotherapeutics
$25.85
$3.17B
-72.92
88.00%
6 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$70.93
$2.68B
-13.24
18.32%
12 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$71.14
$3.02B
-35.33
51.62%
6 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$4.67
$2.43B
-2.58
-27.03%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVTX
Travere Therapeutics
27.87
8.41
43.22%
GLPG
Galapagos
33.52
9.69
40.66%
ARQT
Arcutis Biotherapeutics
25.85
12.77
97.63%
IRON
Disc Medicine
70.93
10.41
17.20%
TARS
Tarsus Pharmaceuticals
71.14
24.40
52.20%
RXRX
Recursion Pharmaceuticals
4.67
-2.21
-32.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts